No added benefit proven for umeclidinium/vilanterol in COPD
Monday, October 20, 2014 - 14:31
in Health & Medicine
There are hardly any evaluable data for patients with moderate COPD severity and for patients with few exacerbations; for higher severity grades with more exacerbations, evaluable data are lacking completely, studies show.